UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 27, 2011
AmerisourceBergen
Corporation
(Exact name of registrant as
specified in its charter)
| Delaware | 1-16671 | 23-3079390 | ||
| (State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 1300 Morris
Drive Chesterbrook, PA |
19087 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (610) 727-7000
| N/A |
| (Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On September 27, 2011, AmerisourceBergen Corporation (the “Registrant”) issued a news release announcing that it has signed a definitive agreement to purchase TheraCom, LLC, a subsidiary of CVS Caremark Corporation, for $250 million, subject to customary working capital adjustments. TheraCom, LLC provides a wide range of support to pharmaceutical and biotechnology drug manufacturers, including consulting and reimbursement services. The transaction is expected to close in the first quarter of the Registrant’s fiscal year 2012, which ends December 31, 2011. TheraCom, LLC will join the Lash Group as part of AmerisourceBergen Consulting Services.
The news release issued on September 27, 2011 is filed as Exhibit 99.1 to this report and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 News Release, dated September 27, 2011, regarding AmerisourceBergen Corporation’s agreement to acquire TheraCom, LLC.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMERISOURCEBERGEN CORPORATION
Date: September 27, 2011
By: /s/ Michael D.
DiCandilo
Name: Michael D. DiCandilo
Title: Executive Vice President
and
Chief Financial Officer